Influence of tumour necrosis factor microsatellite polymorphisms on susceptibility to head and neck cancer

Acta Oto-Laryngologica

Volumn 118, Issue 2, 1998, Pages 284-288

  Matthias, C ^a   Jahnke, V ^a   Fryer, A ^b   Strange, R ^b   Ollier, W ^c   Hajeer, A ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Gene polymorphisms; Genetic risk factors; Laryngeal cancer risk

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 6P; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEAD AND NECK CANCER; HLA TYPING; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ALLELES; CARCINOMA, SQUAMOUS CELL; DISEASE SUSCEPTIBILITY; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MICROSATELLITE REPEATS; PHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031893076     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016489850155035     Document Type: Article

References (21)

1. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995; 75: 147-53.
2. Jahnke V, Bösartige Tumoren des Larynx. In: Naumann HH, Helms J, Herberhold C, Kastenbauer E, eds. Oto-Rhino-Laryngologie in Klinik und Praxis. Vol 3. Stuttgart: Georg Thieme, 1995: 388-421.
3. Blot WJ, McLaughlin JK, Winn DM. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7.
4. Brugere J, Guenel P, Leclerc A, et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer 1986; 57: 391-5.
5. Copper MP, Jovanovic A, Nauta JJP et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol (Stockh) 1995; 121: 157-60.
6. Trizna Z, Clayman GL, Spitz MR et al. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am J Surg 1995; 170: 499-501.
7. Henning S, Cascorbi I, Jahnke V et al. Rapid arylamine-N-acetyltransferase (NAT2) - a susceptibility factor for laryngeal cancer (abstract). Fourth International Conference on Head and Neck Cancer, Toronto, 1996.
8. Jahnke V, Strange RC, Matthias C et al. Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma. Laryngorhinotologie 1995; 74: 691-4.
9. Matthias C, Bockmühl U, Jahnke V et al. Susceptibility to oral pharyngeal and laryngeal carcinomas: influence of polymorphism in glutathione S-transferase GSTM3. Carcinogenesis. (in press).
10. deVries N, Drexhage HH, deWaal LP et al. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer 1987; 60: 957-61.
11. Verjans GM, Messer G, Weiss EH et al. Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheum Dis Clin North Am 1992; 18: 177-86.
12. Carroll MC, Katzman P, Alicot EM et al. Linkage or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci USA 1990; 87: 9794-9.
13. Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 1990; 4: 3215-8.
14. Lochead JA, Chalmers IM, Marshall WH et al. HLA-B 27 haplotypes in family studies of ankylosing spondylitis. Arthritis Rheum 1983; 26: 1101-6.
15. Parks RR, Yan SD, Huang CC. Tumor necrosis factor-α production in human head and neck squamous cell carcinoma. Laryngoscope 1994; 104: 860-4.
16. Fugger L, Morling N, Ryder LP et al. NCO restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF-α) region in four autoimmune disease. Tissue Antigens 1989; 34: 17-21.
17. Udalova IA, Nedospasov SA, Webb GC et al. Highly informative typing of the human TNF locus using 6 adjacent polymorphic markers. Genomics 1993; 16: 180-4.
18. Pocoit F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-31.
19. Knerer B, Hulla W, Martinek H et al. IL-1 and TNF-α but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR. Acta Otolaryngol (Stockh) 1996; 116: 132-6.
20. Honchel R, McDonnell S, Schaid DJ et al. Tumor necrosis factor-α allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer. Cancer Res 1996; 56: 145-9.
21. Crouau-Roy B, Briant L, Boussiou C et al. Tumor necrosis factor microsatellites in four European populations. Hum Immunol 1993; 38: 213-6.